Skip to main content

Telesis Bio Inc.

TBIODelisted Sep 20, 2024
Industry
Laboratory Analytical Instruments
SEC CIK
0001850079

Telesis Bio Inc. was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Jul 26, 2024; 21 institutions reported holding it in 13F filings for Q1 2024, worth $4.77M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Telesis Bio Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of TBIO: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders4043+3
Shares6.32M6.90M+585.9K (+9.3%)
Value$138.6M$76.8M−$61.8M (−44.6%)

New holders (20)

Institutions that held Telesis Bio Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to TBIO in Q3 2021
InstitutionSharesValue% of portfolio
Ophir Asset Management Pty Ltd661,118$7.36M1.02%
State Street Corp71,621$797.0K0.00%
Northern Trust Corp62,374$694.0K0.00%
D. E. Shaw & Co., Inc.19,945$222.0K0.00%
Charles Schwab Investment Management Inc15,605$174.0K0.00%
Bank of New York Mellon Corp14,140$157.0K0.00%
Walleye Capital LLC11,067$123.0K0.00%
Deutsche Bank AG4,462$50.0K0.00%
American International Group, Inc.4,244$47.0K0.00%
California State Teachers Retirement System4,190$47.0K0.00%
JPMorgan Chase & Co2,970$33.0K0.00%
STRS Ohio1,800$20.0K0.00%
Citigroup Inc884$10.0K0.00%
Royal Bank of Canada946$10.0K0.00%
Tower Research Capital LLC (TRC)889$10.0K0.00%
Legal & General Group Plc722$8.00K0.00%
Ameritas Investment Partners, Inc.595$7.00K0.00%
Bank of America Corp508$6.00K0.00%
New York State Common Retirement Fund545$6.00K0.00%
Wells Fargo & Company268$3.00K0.00%

Sold out (17)

Institutions that held Telesis Bio Inc. at the end of Q2 2021 and filed for Q3 2021 without it.